Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 23 Breast Neoplasms 22 Colorectal Neoplasms 14 Ovarian Neoplasms 12 Lung Neoplasms 10 Neoplasm Metastasis 9 Stomach Neoplasms 8 Neoplasms 8 Nasopharyngeal Carcinoma 8 Leukemia, Myeloid, Acute 7 Triple Negative Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Rectal Neoplasms 6 Fallopian Tube Neoplasms 6 Recurrence 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Esophageal Squamous Cell Carcinoma 5 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Lymphoma, Non-Hodgkin 4 Leukemia 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Pancreatic Neoplasms 3 Neoplasms by Site 3 Lymphoma, Large B-Cell, Diffuse 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Multiple Myeloma 2

Interventions

Gemcitabine 13 Cisplatin 11 durvalumab 7 Oxaliplatin 5 Capecitabine 5 Fluorouracil 4 S 1 (combination) 3 Leucovorin 3 Irinotecan 3 zanidatamab 2 gemcitabine-oxaliplatin regimen 2 Trastuzumab 2 trastuzumab deruxtecan 1 pembrolizumab 1 niraparib 1 neratinib 1 ivosidenib 1 futibatinib 1 envafolimab 1 encorafenib 1 binimetinib 1 becatecarin 1 Tegafur 1 Pancreaticojejunostomy 1 NUC-1031 1 Folfox protocol 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Biliary Tract Neoplasms × Drug Therapy × Clear all

NCT07062263 2025-07-14

TAB-2

Tata Memorial Centre

Phase 3 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡